Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 4
1974 4
1975 2
1976 1
1977 6
1978 6
1979 5
1980 10
1981 6
1982 7
1983 10
1984 8
1985 7
1986 7
1987 9
1988 13
1989 9
1990 11
1991 15
1992 14
1993 9
1994 13
1995 8
1996 6
1997 4
1998 8
1999 7
2000 6
2001 2
2002 3
2003 6
2004 7
2005 9
2006 4
2007 5
2008 7
2009 3
2010 4
2011 3
2013 2
2014 4
2015 2
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

274 results
Results by year
Filters applied: . Clear all
Page 1
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.
Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, André F, Delaloge S, Tursz T, Kroemer G, Zitvogel L. Apetoh L, et al. Among authors: tursz t. Nat Med. 2007 Sep;13(9):1050-9. doi: 10.1038/nm1622. Epub 2007 Aug 19. Nat Med. 2007. PMID: 17704786
Malignant effusions and immunogenic tumour-derived exosomes.
Andre F, Schartz NE, Movassagh M, Flament C, Pautier P, Morice P, Pomel C, Lhomme C, Escudier B, Le Chevalier T, Tursz T, Amigorena S, Raposo G, Angevin E, Zitvogel L. Andre F, et al. Among authors: tursz t. Lancet. 2002 Jul 27;360(9329):295-305. doi: 10.1016/S0140-6736(02)09552-1. Lancet. 2002. PMID: 12147373
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial.
Escudier B, Dorval T, Chaput N, André F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L. Escudier B, et al. Among authors: tursz t. J Transl Med. 2005 Mar 2;3(1):10. doi: 10.1186/1479-5876-3-10. J Transl Med. 2005. PMID: 15740633 Free PMC article.
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Santoro A, Tursz T, Mouridsen H, Verweij J, Steward W, Somers R, Buesa J, Casali P, Spooner D, Rankin E, et al. Santoro A, et al. Among authors: tursz t. J Clin Oncol. 1995 Jul;13(7):1537-45. doi: 10.1200/JCO.1995.13.7.1537. J Clin Oncol. 1995. PMID: 7602342 Clinical Trial.
Exosomes for cancer immunotherapy.
Andre F, Escudier B, Angevin E, Tursz T, Zitvogel L. Andre F, et al. Among authors: tursz t. Ann Oncol. 2004;15 Suppl 4:iv141-4. doi: 10.1093/annonc/mdh918. Ann Oncol. 2004. PMID: 15477298 Free article. Review. No abstract available.
Hurdles on the road to personalized medicine.
Tursz T, Bernards R. Tursz T, et al. Mol Oncol. 2015 May;9(5):935-9. doi: 10.1016/j.molonc.2014.08.009. Epub 2014 Aug 30. Mol Oncol. 2015. PMID: 25226812 Free PMC article. Review.
Perez M, Masse R, Tursz T, Dubois G. Perez M, et al. Among authors: tursz t. Bull Acad Natl Med. 2014 Dec;198(9):1621-8. Bull Acad Natl Med. 2014. PMID: 27356363 French. No abstract available.
Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
Viaud S, Théry C, Ploix S, Tursz T, Lapierre V, Lantz O, Zitvogel L, Chaput N. Viaud S, et al. Among authors: tursz t. Cancer Res. 2010 Feb 15;70(4):1281-5. doi: 10.1158/0008-5472.CAN-09-3276. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145139 Free article. Review.
274 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page